COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 296 participants.
Also called NCT01925794
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 296 participants
- Sponsor
- CeloNova BioSciences, Inc.
- Registry
-
NCT01925794
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, France, Germany, Latvia, Serbia, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01925794. Allocation not applicable; no masking; primary purpose treatment. Start 2013-08-21 (registry gives no type); primary completion 2015-11 (actual). Results posted on 2021-12-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
- Condition
- Coronary Artery Disease
- Intervention (Device)
- COBRA PzF
- Lead sponsor
- CeloNova BioSciences, Inc.
Record details
- Record id
cardio:ct-nct01925794- Content hash
bbd82eb8cbb225dfa131a076cf48da26bf1a726fe0f994763c4262530ab91f3f